Axsome Therapeutics AXSM Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $305.11M-5.5% | $322.93M-0.7% | $325.27M+7.3% | $303.02M+0.7% | $300.91M-4.6% | ||
| $251.06M+11.8% | $224.46M+14.2% | $196.51M-1.2% | $198.83M+23.2% | $161.4M+13.7% | ||
| $31.52M+12.8% | $27.94M+17.5% | $23.77M+28.9% | $18.44M+13.0% | $16.32M+3.7% | ||
| $23.52M+72.3% | $13.65M-31.0% | $19.79M+21.1% | $16.34M+2.1% | $16.01M+33.6% | ||
| $611.21M+3.8% | $588.99M+4.2% | $565.34M+5.4% | $536.62M+8.5% | $494.63M+2.0% | ||
| $567K+0.9% | $562K-7.1% | $605K-9.3% | $667K-13.7% | $773K+32.4% | ||
| $20.01M-4.0% | $20.86M-3.7% | $21.65M-3.6% | $22.47M-3.5% | $23.29M+333% | ||
| $12.04M0.0% | $12.04M0.0% | $12.04M0.0% | $12.04M0.0% | $12.04M0.0% | ||
| $38.95M-3.9% | $40.52M-3.8% | $42.13M-3.7% | $43.73M-3.5% | $45.32M-3.4% | ||
| $713.61M+3.5% | $689.81M+3.1% | $669.25M+4.6% | $639.79M+7.2% | $596.67M+5.0% | ||
| $106.7M+62.8% | $65.54M+20.9% | $54.23M-40.8% | $91.63M+7.0% | $85.66M+19.0% | ||
| $70M— | —— | —— | —— | —— | ||
| $628K+44.7% | $434K-41.0% | $736K+118% | $337K-25.8% | $454K-75.3% | ||
| $3.19M+25.5% | $2.55M+1.9% | $2.5M+24.0% | $2.01M+10.9% | $1.82M+27.8% | ||
| $439.21M+15.9% | $378.84M+5.1% | $360.29M+5.3% | $342.1M+40.3% | $243.91M+6.0% | ||
| $117.85M+0.1% | $117.75M+0.1% | $117.64M+0.1% | $117.54M-35.2% | $181.38M+0.4% | ||
| $22.39M-3.4% | $23.18M+0.6% | $23.04M-2.5% | $23.62M-1.2% | $23.91M+295% | ||
| $9.04M+33.9% | $6.75M-5.9% | $7.18M+23.6% | $5.81M+5.6% | $5.5M+25.9% | ||
| $23.01M-2.6% | $23.62M-0.7% | $23.78M-0.8% | $23.96M-1.6% | $24.36M+209% | ||
| $5.84M+38.9% | $4.21M-10.1% | $4.68M+23.4% | $3.79M+3.0% | $3.68M+25.0% | ||
| $659.02M+9.6% | $601.51M+1.0% | $595.52M+5.1% | $566.71M+4.3% | $543.47M+6.3% | ||
| $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | ||
| $1.43B+2.2% | $1.39B+3.2% | $1.35B+3.7% | $1.3B+5.5% | $1.24B+4.7% | ||
| -$1.37B-4.9% | -$1.31B-2.2% | -$1.28B-3.8% | -$1.23B-4.1% | -$1.18B-5.3% | ||
| $54.59M-38.2% | $88.3M+19.8% | $73.73M+0.9% | $73.08M+37.3% | $53.21M-6.7% | ||
| $713.61M+3.5% | $689.81M+3.1% | $669.25M+4.6% | $639.79M+7.2% | $596.67M+5.0% | ||
| $20.01M-4.0% | $20.86M-3.7% | $21.65M-3.6% | $22.47M-3.5% | $23.29M+333% | ||
| $38.95M-3.9% | $40.52M-3.8% | $42.13M-3.7% | $43.73M-3.5% | $45.32M-3.4% | ||
| $20.01M-4.0% | $20.86M-3.7% | $21.65M-3.6% | $22.47M-3.5% | $23.29M+333% | ||
| $30.83M+14.9% | $26.84M-2.3% | $27.48M+13.3% | $24.25M+17.7% | $20.61M+11.2% | ||
| $20.01M-4.0% | $20.86M-3.7% | $21.65M-3.6% | $22.47M-3.5% | $23.29M+333% | ||
| $250.73M+7.7% | $232.85M+3.2% | $225.63M+32.0% | $170.9M+14.5% | $149.2M+0.8% | ||
| $73.73M-4.9% | $77.54M-13.7% | $89.87M+12.8% | $79.66M-12.1% | $90.59M-1.2% | ||
| $219.9M+0.8% | $218.11M-0.2% | $218.6M+0.6% | $217.31M+2.9% | $211.23M+9.5% | ||
| $1.43B+2.2% | $1.39B+3.2% | $1.35B+3.7% | $1.3B+5.5% | $1.24B+4.7% | ||
| $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | ||
| $3.19M+25.5% | $2.55M+1.9% | $2.5M+24.0% | $2.01M+10.9% | $1.82M+27.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Axsome Therapeutics's total assets?
- Axsome Therapeutics (AXSM) holds $713.6M in total assets, up 19.6% year over year.
- How much debt does Axsome Therapeutics have?
- Axsome Therapeutics carries $219.9M in total debt against $54.6M of shareholders' equity, a debt-to-equity ratio of 4.03.
- How much cash does Axsome Therapeutics have?
- Axsome Therapeutics holds $305.1M in cash and equivalents.
- Can Axsome Therapeutics cover its short-term obligations?
- Its current ratio is 1.39 — current assets exceed current liabilities.
- Where does Axsome Therapeutics's balance sheet data come from?
- Every line is extracted from Axsome Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
